Aims to Pair BD Antigen Test with Scanwell Health Mobile App FRANKLIN LAKES, N.J. , Feb. 22, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, and Scanwell Health , a leader in smartphone-enabled at-home medical tests, today
FRANKLIN LAKES, N.J. , Feb. 12, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following upcoming virtual investor conferences: The Leerink Virtual 10th Annual Global Healthcare
New single test for the BD MAX™ System also shows ability to detect U.K., South African Variants FRANKLIN LAKES, N.J. , Feb. 12, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced that the U.S.
- First fiscal quarter revenues of $5.315 billion grew 25.8% on a reported basis. On a currency-neutral basis, revenues increased 24.3%. - BD's COVID-19 testing sales of $867 million contributed 20.5 percentage points to revenue growth on a reported basis.
- There is robust evidence that the BD vascular care solution and skin antiseptic for peripheral intravenous catheters used in the CLEAN3 randomized clinical trial can help improve patient outcomes - Compared with standard approaches, the BD vascular care solution reduced the relative risk of
Polen to Succeed Vince Forlenza Effective April 28 FRANKLIN LAKES, N.J. , Jan. 26, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen , BD CEO and president, will assume additional responsibility as chairman